Rankings
▼
Calendar
ACAD Q4 2019 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
ACAD
ACADIA Pharmaceuticals Inc.
$4B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$98M
+65.1% YoY
Gross Profit
$93M
94.6% margin
Operating Income
-$56M
-57.4% margin
Net Income
-$53M
-53.9% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
+4.0%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$30M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$783M
Total Liabilities
$84M
Stockholders' Equity
$699M
Cash & Equivalents
$190M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$98M
$60M
+65.1%
Gross Profit
$93M
$55M
+68.5%
Operating Income
-$56M
-$67M
+16.2%
Net Income
-$53M
-$65M
+19.0%
← FY 2019
All Quarters
Q1 2020 →